Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.

预酸化 外周血单个核细胞 药理学 转移酶 药效学 化学 医学 体外 生物化学 药代动力学
作者
Robert B. Lobell,Dongming Liu,Carolyn A. Buser,Joseph P. Davide,Elizabeth DePuy,Kelly Hamilton,Kenneth S. Koblan,Yih Lee,Scott D. Mosser,Sherri L. Motzel,James L. Abbruzzese,Charles S. Fuchs,Eric K. Rowinsky,Eric H. Rubin,Sunil Sharma,Paul Deutsch,Kathryn Mazina,Briggs Morrison,Lynne Wildonger,Siu-Long Yao,Nancy E. Kohl
出处
期刊:PubMed 卷期号:1 (9): 747-58 被引量:119
链接
标识
摘要

Farnesyl:protein transferase (FPTase) inhibitors were developed as anti-Ras drugs, but they fail to inhibit Ki-Ras activity because Ki-Ras can be modified by geranylgeranyl:protein transferase type-I (GGPTase-I). L-778,123, an inhibitor of FPTase and GGPTase-I, was developed in part because it can completely inhibit Ki-Ras prenylation. To support the clinical development of L-778,123, we developed pharmacodynamic assays using peripheral blood mononuclear cells (PBMCs) to measure the inhibition of prenylation of HDJ2 and Rap1A, proteins that are FPTase- and GGPTase-I substrates, respectively. We validated these assays in animal models and show that inhibition of HDJ2 prenylation in mouse PBMCs correlates with the concentration of FPTase inhibitors in blood. In dogs, continuous infusion of L-778,123 inhibited both HDJ2 and Rap1A prenylation in PBMCs, but we did not detect inhibition of Ki-Ras prenylation. We reported previously results from the first L-778,123 Phase I trial that showed a dose-dependent inhibition of HDJ2 farnesylation in PBMCs. In this report, we present additional analysis of patient samples from this trial and a second Phase I trial of L-778,123, and demonstrate the inhibition of both HDJ2 and Rap1A prenylation in PBMC samples. This study represents the first demonstration of GGPTase-I inhibition in humans. However, no inhibition of Ki-Ras prenylation by L-778,123 was detected in patient samples. These results confirm the pharmacologic profile of L-778,123 in humans as a dual inhibitor of FPTase and GGPTase-I, but indicate that the intended target of the drug, Ki-Ras, was not inhibited.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
易大师完成签到,获得积分10
刚刚
荒草瓦砾发布了新的文献求助10
刚刚
Otorhino完成签到 ,获得积分10
刚刚
刚刚
刚刚
温暖的问候完成签到,获得积分10
刚刚
乐乐应助邓力采纳,获得10
刚刚
1秒前
yang发布了新的文献求助10
1秒前
无心的晓兰完成签到 ,获得积分10
1秒前
shi发布了新的文献求助10
2秒前
2秒前
2秒前
JofferyChan发布了新的文献求助10
2秒前
3秒前
狂野傲薇发布了新的文献求助10
3秒前
粒粒李完成签到,获得积分10
3秒前
3秒前
SciGPT应助好运滚滚来采纳,获得10
5秒前
Crazyjmj发布了新的文献求助10
6秒前
ZJY发布了新的文献求助10
6秒前
7秒前
充电宝应助罗小黑采纳,获得10
7秒前
7秒前
炝拌维C完成签到 ,获得积分10
7秒前
7秒前
荒草瓦砾完成签到,获得积分10
8秒前
微微发布了新的文献求助10
8秒前
所所应助Otorhino采纳,获得10
8秒前
斯文谷秋发布了新的文献求助10
8秒前
8秒前
junze完成签到,获得积分10
10秒前
Swan完成签到 ,获得积分10
10秒前
matchais1ife完成签到 ,获得积分10
10秒前
JamesPei应助qaw采纳,获得10
11秒前
learn应助狂野傲薇采纳,获得10
12秒前
12秒前
顺心的筮发布了新的文献求助10
12秒前
JofferyChan完成签到,获得积分10
12秒前
高分求助中
Sustainability in Tides Chemistry 2000
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 600
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufe 600
A Dissection Guide & Atlas to the Rabbit 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3105631
求助须知:如何正确求助?哪些是违规求助? 2756681
关于积分的说明 7641226
捐赠科研通 2410796
什么是DOI,文献DOI怎么找? 1279097
科研通“疑难数据库(出版商)”最低求助积分说明 617641
版权声明 599262